(Q79321294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

3

Sven Erik Dahlén

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

4

Jean Bousquet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Maria Kumlin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Philippe Godard

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Pascal Chanez

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1225-1229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

Treatment of asthma with drugs modifying the leukotriene pathway.

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Inhalation challenge with sulfidopeptide leukotrienes in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Characteristics of formation and further metabolism of leukotrienes in the chopped human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Urinary leukotriene E4 excretion in exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Recovery of Leukotriene E4from the Urine of Patients with Airway Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Anti-inflammatory mechanisms of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Measurement of leukotrienes in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Leukotrienes in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Lipoxins are potential endogenous antiinflammatory mediators in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Urinary leukotriene E4 in the assessment of nocturnal asthma†

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D(4) in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900253-1

7 January 2021

10.1016/S0954-6111(03)00253-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635978%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference